These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25762375)

  • 1. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.
    Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y
    Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.
    Ren TH; Lv MM; An XM; Leung WK; Seto WK
    J Dig Dis; 2020 Jan; 21(1):38-45. PubMed ID: 31714673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
    Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
    Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor.
    Wu W; He Y; Feng X; Ye S; Wang H; Tan W; Yu C; Hu J; Zheng R; Zhou Y
    Oncotarget; 2017 Jan; 8(1):705-721. PubMed ID: 27893428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
    Fishman P; Bar-Yehuda S; Madi L; Rath-Wolfson L; Ochaion A; Cohen S; Baharav E
    Arthritis Res Ther; 2006; 8(1):R33. PubMed ID: 16507132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
    Mlejnek P; Dolezel P; Kosztyu P
    J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction.
    Hussain A; Gharanei AM; Nagra AS; Maddock HL
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):19-32. PubMed ID: 24220799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis.
    Lee HT; Kim M; Joo JD; Gallos G; Chen JF; Emala CW
    Am J Physiol Regul Integr Comp Physiol; 2006 Oct; 291(4):R959-69. PubMed ID: 16728466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased A3AR-dependent vasoconstriction in diabetic mice is promoted by myeloperoxidase.
    Nishat S; Klinke A; Baldus S; Khan LA; Basir SF
    J Cardiovasc Pharmacol; 2014 Nov; 64(5):465-72. PubMed ID: 25000478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of adenosine A3 receptor alleviates TNF-α-induced inflammation through inhibition of the NF-κB signaling pathway in human colonic epithelial cells.
    Ren T; Qiu Y; Wu W; Feng X; Ye S; Wang Z; Tian T; He Y; Yu C; Zhou Y
    Mediators Inflamm; 2014; 2014():818251. PubMed ID: 24864134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells.
    Lee JY; Jhun BS; Oh YT; Lee JH; Choe W; Baik HH; Ha J; Yoon KS; Kim SS; Kang I
    Neurosci Lett; 2006 Mar; 396(1):1-6. PubMed ID: 16324785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
    Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P
    Clin Exp Rheumatol; 2006; 24(4):400-6. PubMed ID: 16956430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway.
    Jafari SM; Panjehpour M; Aghaei M; Joshaghani HR; Enderami SE
    J Cell Biochem; 2017 Sep; 118(9):2909-2920. PubMed ID: 28230290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A3 receptor activation inhibits pronociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neurons.
    Coppi E; Cherchi F; Fusco I; Failli P; Vona A; Dettori I; Gaviano L; Lucarini E; Jacobson KA; Tosh DK; Salvemini D; Ghelardini C; Pedata F; Di Cesare Mannelli L; Pugliese AM
    Pain; 2019 May; 160(5):1103-1118. PubMed ID: 31008816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis.
    Mabley J; Soriano F; Pacher P; Haskó G; Marton A; Wallace R; Salzman A; Szabó C
    Eur J Pharmacol; 2003 Apr; 466(3):323-9. PubMed ID: 12694816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors.
    Tian Y; Marshall M; French BA; Linden J; Yang Z
    Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
    J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.
    Varani K; Padovan M; Vincenzi F; Targa M; Trotta F; Govoni M; Borea PA
    Arthritis Res Ther; 2011; 13(6):R197. PubMed ID: 22146575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo.
    Butler M; Sanmugalingam D; Burton VJ; Wilson T; Pearson R; Watson RP; Smith P; Parkinson SJ
    Eur J Immunol; 2012 Dec; 42(12):3358-68. PubMed ID: 23027555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.